この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2001/8/151 分で読めます
Ophthalmic and Topical Dosage Form New Animal Drugs; Chloramphenicol, etc.; Withdrawal of Approval of NADAs
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending the animal drug regulations to remove those portions that reflect approval of two new animal drug applications (NADAs) held by EVSCO Pharmaceuticals, an Affiliate of IGI, Inc. In a notice published elsewhere in this issue of the Federal Register, FDA is withdrawing approval of these NADAs.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →